HEAD AND NECK - TREATMENT OF PRIMARY AND RELAPSED NASOPHARYNGEAL CARCINOMA

被引：0
|
作者：
WANG, CC [1 ]
机构：
[1] MASSACHUSETTS GEN HOSP, DEPT RADIAT ONCOL, BOSTON, MA 02114 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1993年 / 27卷
关键词：
D O I：
10.1016/0360-3016(93)90573-E
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：99 / 99
页数：1
相关论文
共 50 条
  • [21] SURGICAL PATHOLOGY OF THE HEAD AND NECK - CASE-9 - DIAGNOSIS - METASTATIC UNDIFFERENTIATED CARCINOMA (LYMPHOEPITHELIOMA), NASOPHARYNGEAL PRIMARY
    TAXY, JB
    MODERN PATHOLOGY, 1992, 5 (06) : 677 - 678
  • [22] Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region
    Psyrri, A
    Fountzilas, G
    MEDICAL ONCOLOGY, 2006, 23 (01) : 1 - 15
  • [23] Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region
    Psyrri A.
    Fountzilas G.
    Medical Oncology, 2006, 23 (1) : 1 - 15
  • [24] Diagnostic accuracy of diffusion-weighted MR imaging for nasopharyngeal carcinoma, head and neck lymphoma and squamous cell carcinoma at the primary site
    Fong, Devin
    Bhatia, Kunwar S. S.
    Yeung, David
    King, Ann D.
    ORAL ONCOLOGY, 2010, 46 (08) : 603 - 606
  • [25] Effect of Primary Site and Treatment Modality of Patients With Head and Neck Myoepithelial Carcinoma on Survival
    Gui, L.
    He, X.
    Zhu, Y.
    Zhang, Y.
    Tang, L.
    Yao, J.
    CLINICAL ONCOLOGY, 2024, 36 (07) : e171 - e181
  • [26] MODELLING DIFFERENTIAL TREATMENT OUTCOMES IN PRIMARY AND NODAL SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Hartley, A.
    Sanghera, P.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S39 - S39
  • [27] Prevalence, prognosis, and treatment implications of retropharyngeal nodes in unknown primary head and neck carcinoma
    Horowitz, Gilad
    Hosni, Ali
    Yu, Eugene
    Xu, Wei
    Lu, Lin
    Au, Michael
    Dixon, Peter R.
    Brown, Dale
    Chepeha, Douglas B.
    Gilbert, Ralph W.
    Goldstein, David P.
    Gullane, Patrick J.
    Irish, Jonathan C.
    Bayley, Andrew
    Cho, John
    Giuliani, Meredith
    Huang, Shao Hui
    Hope, Andrew
    Kim, John
    O'Sullivan, Brian
    Ringash, Jolie
    Waldron, John
    Weinreb, Ilan
    Perez-Ordonez, Bayardo
    Bratman, Scott V.
    de Almeida, John R.
    ORAL ONCOLOGY, 2018, 82 : 162 - 167
  • [28] Treatment and outcomes of second primary tumors in patients with head and neck squamous cell carcinoma
    Siripoon, T.
    Pattaranutaporn, P.
    Jiarpinitnun, C.
    Juengsamarn, J.
    Bunbanjerdsuk, S.
    Jinawath, N.
    Ngamphaiboon, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] Current role of primary surgical treatment in patients with head and neck squamous cell carcinoma
    Bozec, Alexandre
    Culie, Dorian
    Poissonnet, Gilles
    Dassonville, Olivier
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 138 - 145
  • [30] Gemcitabine for patients with relapsed nasopharyngeal carcinoma
    Mileshkin, L
    Rischin, D
    INTERNAL MEDICINE JOURNAL, 2002, 32 (5-6) : 275 - 276
12345